In recent years, immune checkpoint regulators such as Programmed Death Receptor 1 (PD-1)/Programmed cell death 1 ligand 1 (PD-L1) have emerged as effective targets for cancer therapy, garnering increasing attention12. The gene discussed is CD274; the disease is cancer.